This journal offers authors two choices to publish their research:
|Gold Open Access||Subscription|
|Articles are freely available to both subscribers and the wider public with permitted reuse.||Articles are made available to subscribers as well as developing countries and patient groups through our access programs.|
|An open access publication fee is payable by authors or their research funder.||No open access publication fee.|
In accordance with Funding Body requirements, Elsevier does offer alternative open access publishing options. Visit our open access page for full information.
Your publication choice will have no effect on the peer review process or acceptance of your submission.Details on Gold Open Access Articles:
User RightsAll articles published gold open access will be immediately and permanently free for everyone to read and download. We offer authors a choice of user licenses, which define the permitted reuse of articles. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows:
Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND): for non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.If you need to comply with your funding body policy you can apply for the CC BY license after your manuscript is accepted for publication.
For members of the American Society for Investigative Pathology and members of the Association for Molecular Pathology, the gold open access publication fee is USD 2400, excluding taxes. For non-members the gold open access publication fee is USD 3000, excluding taxes. Learn more about Elsevier's pricing policy.Funding Body Agreements
Elsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Green Open Access (e.g. self-archiving)Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our open access page for further information. An author can also self-archive their author manuscript immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.
An author is entitled to post the accepted manuscript in their institution's repository and make this public after an embargo period (known as green Open Access). The embargo period for this journal can be found below.The published journal article cannot be shared publicly, for example on ResearchGate or Academia.edu, to ensure the sustainability of peer-reviewed research in journal publications.
For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before a manuscript becomes available for free to the public. This is called an embargo period and it begins from the date the article is formally published online in its final and fully citable form. Find out more
This journal has an embargo period of 12 months.
• Publishing open access with Elsevier
• Funding body agreements
• Open access license policy
• Open access pricing policyContact Details
Journal Article Publishing Support Center